The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The effects of a 10 day administration of clomipramine (25-50 mg t.i.d.), alprazolam (0.25-0.75 mg t.i.d.) and placebo were assessed in normal volunteers in a double-blind cross-over study. A battery of physiological, psychomotor and cognitive tests was administered both before and 3 h after drug on days 1, 5 and 10. The effects of alprazolam on EEG and evoked potentials were characteristic of benzodiazepines; clomipramine had little effect. In contrast, reaction speed was markedly slowed by clomipramine but little affected by alprazolam. Neither drug produced any accumulation of effect on a verbal recall task but neither did tolerance develop to the acute impairments produced by active treatments. Alprazolam produced an increase in levels of forgetting, especially on day 5. Subjective ratings for mood and bodily symptoms were adversely affected by clomipramine but little altered by alprazolam. It is suggested that some of the differences between drug treatments may be due to differences in the speed of onset of tolerance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, no tolerance for memory-impairing effects of alprazolam was found during a 10-day acute treatment [41].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [41]
In the citing paper
“Moreover, tolerance to benzodiazepine-induced decreased reaction speed was shown after 10 days of alprazolam treatment [41].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [41]
Citations
Cites
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
Battig, W. F., & Montague, W. E. (1969) · Journal of Experimental Psychology · doi:10.1037/h0027577 · Cited by 2,570
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972 · cited 1×
“A principal component analysis of this scale has yielded three factors [Bond and Lader 1974] namely, 'alertness' (Mood Factor 1), 'contentedness' (Mood Factor 2) and 'calmness' (Mood Factor 3).”
Self-citationThe Cholinergic Synapse and the Site of Memory
Deutsch, J. A. (1971) · Science · doi:10.1126/science.174.4011.788 · Cited by 661 · cited 1×
“Learning and memory are thought to involve cholinergic mediation [Deutsch 1971; Drachman 1978] so that antidepressants with anticholinergic effects may produce impairments in people's ability to learn and remember.”
BackgroundBallenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564 · cited 1×
“…has also been shown to be effective in treating panic disorders [Chouinard et al. 1982; Alexander and Alexander 1986; Ballenger et al. 1988] and, in contrast to antidepressants appears to be well tolerated by patients and to have minimal side effects [Noyes et al.…”
ResultPsychopharmacology: A Generation of Progress
Abrams, A. A. (1978) · Psychosomatic Medicine · doi:10.1097/00006842-197810000-00010 · Cited by 416
Tranquillising memories: A review of the effects of benzodiazepines on human memory
Curran, H. V. (1986) · Biological Psychology · doi:10.1016/0301-0511(86)90081-5 · Cited by 298 · cited 2×
“Benzodiazepines also have clear sedative properties and the degree to which their amnesic effects are by-products of changes in arousal levels is also a question of debate [ Curran 1986; Roth et al. 1984].”
BackgroundResultSelf-citationChouinard, G., Annable, L., Fontaine, R., & Solyom, L. (1982) · Psychopharmacology · doi:10.1007/bf00464571 · Cited by 256 · cited 1×
“The triazolo-benzodiazepine, alprazolam, has also been shown to be effective in treating panic disorders [Chouinard et al. 1982; Alexander and Alexander 1986; Ballenger et al. 1988] and, in contrast to antidepressants appears to be well tolerated by patients and to have minimal side effects [Noyes et al.”
BackgroundPecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204 · cited 1×
“On the debit side, discontinuation of alprazolam may present some problems [Pecknold et al. 1988].”
BackgroundMcTavish, D., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199039010-00010 · Cited by 161
The SHP Test—an Aid in the Detection and Measurement of Depression
PECK, R. E. (1959) · Archives of General Psychiatry · doi:10.1001/archpsyc.1959.03590010051006 · Cited by 153
Noyes, R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290037005 · Cited by 116 · cited 1×
“1988] and, in contrast to antidepressants appears to be well tolerated by patients and to have minimal side effects [Noyes et al. 1988].”
ResultTreatment of spontaneous panic attacks with chlomipramine
(1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.9.1215 · Cited by 115
Memory and performance effects of single and 3-week administration of diazepam
Ghoneim, M. M., Mewaldt, S. P., Berie, J. L., & Hinrichs, J. V. (1981) · Psychopharmacology · doi:10.1007/bf00429206 · Cited by 113 · cited 1×
“It does seem that tolerance to the sedative effects of benzodiazepines builds up over repeated dosing but as Ghoneim et al. (1981) found, some memory impairments may persist over a period of weeks.”
BackgroundAlprazolam Kinetics in the Elderly: Relation to Antipyrine Disposition
Greenblatt, D. J. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790030057007 · Cited by 104
Antidepressants in panic disorder and agoraphobia
Lydiard, R. B., & Ballenger, J. C. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90020-6 · Cited by 97 · cited 2×
“It is now well established, both from controlled trials and clinical experience, that the tricyclic antidepressants effectively control panic disorders [see review by Lydiard and Ballenger 1987 ].”
BackgroundCurran, H. V., Sakulsriprong, M., & LADER, M. H. (1988) · Psychopharmacology · doi:10.1007/bf00172967 · Cited by 77 · cited 2×
“The effects of clomipramine on cognitive and psychomotor functions have not been well documented, but other antidepressants such as amitriptyline, impair memory in both volunteer subjects and depressed patients [Branconnier et al. 1982; Lamping et al. 1984; Curran et al. 1988].”
BackgroundSelf-citationSmith, R. B., & Kroboth, P. D. (1987) · Psychopharmacology · doi:10.1007/bf02439595 · Cited by 76
Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo
Greenblatt, D. J., Harmatz, J. S., Dorsey, C., & Shader, R. I. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.158 · Cited by 74
Alprazolam and lorazepam effects on memory acquisition and retrieval processes
Block, R. I., & Berchou, R. C. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90248-x · Cited by 71 · cited 2×
“Single doses of alprazolam produce marked anterograde impairments of memory in studies with normal volunteers [Block and Berchou 1984; Greenblatt et al. 1988].”
BackgroundBond, A. J., LADER, M. H., & Shrotriya, R. C. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609887 · Cited by 63 · cited 1×
“The effects of alprazolam on EEG and evoked response were characteristic of benzodiazepine action [Bond et al. 1983]; little or no tolerance developed over the 10 days treatment period.”
BackgroundSelf-citationRoth, T., Roehrs, T., Wittig, R., & Zorick, F. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02581.x · Cited by 62
Central cholinergic system and memory
Drachman, D. A. (1979) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · Cited by 57
Ciraulo, D. A., Barnhill, J. G., Boxenbaum, H. G., Greenblatt, D. J., & Smith, R. B. (1986) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1986.tb03526.x · Cited by 52
Amitriptyline selectively disrupts verbal recall from secondary memory of the normal aged
Branconnier, R. J., Devitt, D. R., Cole, J. O., & Spera, K. F. (1982) · Neurobiology of Aging · doi:10.1016/0197-4580(82)90061-6 · Cited by 51 · cited 1×
“The effects of clomipramine on cognitive and psychomotor functions have not been well documented, but other antidepressants such as amitriptyline, impair memory in both volunteer subjects and depressed patients [Branconnier et al. 1982; Lamping et al. 1984; Curran et al. 1988].”
BackgroundAlprazolam: Effects on Sleep and Withdrawal Phenomena
Kales, A., Bixler, E. O., Vela‐Bueno, A., Soldatos, C. R., & Manfredi, R. L. (1987) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1987.tb03058.x · Cited by 46
Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study
Lamping, D. L., Spring, B. J., & Gelenberg, A. J. (1984) · Psychopharmacology · doi:10.1007/bf00427455 · Cited by 42 · cited 1×
“The effects of clomipramine on cognitive and psychomotor functions have not been well documented, but other antidepressants such as amitriptyline, impair memory in both volunteer subjects and depressed patients [Branconnier et al. 1982; Lamping et al. 1984; Curran et al. 1988].”
BackgroundAlprazolam treatment for panic disorders.
Pe, A., & Dd, A. (1986) · PubMed · Cited by 37
Aranko, K., Mattila, M. J., & Bordignon, D. (1985) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1985.tb01305.x · Cited by 27 · cited 1×
“Kales et al. (1987) and Aranko et al. (1985) have both reported "rebound phenomena" following withdrawal of alprazolam.”
BackgroundPanic attacks and agoraphobia: low dose clomipramine treatment.
Gloger, S., Grunhaus, L. J., Gladic, D., O'Ryan, F., Cohen, L. J., & Codner, S. (1989) · PubMed · Cited by 26
Gloger, S., Grunhaus, L. J., Gladic, D., RYAN, F. O., COHEN, L., & Codner, S. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198902000-00006 · Cited by 23
Psychotropic Drugs. Plasma Concentration and Clinical Response
Jenner, P. G. (1982) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.8.763-a · Cited by 15
Research works printed but not linked: 2
- Baddeley AD, Sutherland A, Harris J (1982) How well do laboratory-based psychological tests predict patient's performance outside the laboratory? Aging 19: 141?148
- Modigh K (1989) A treatment programme for panic disorder. In: Kielholz P, Adams C (eds) Panic anxiety states. Deutscher Ärzte-Verlag, Köln
Cited by
Cognitive Effects of Long-Term Benzodiazepine Use: A Meta-Analysis
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00004 · Cited by 552
Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia
Heydorn, W. E. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.841 · Cited by 195
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“Moreover, tolerance to benzodiazepine-induced decreased reaction speed was shown after 10 days of alprazolam treatment [41].”
BackgroundVerster, J. C., & Volkerts, E. R. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00003.x · Cited by 150
“For example, significantly reduced N1 and P1 amplitudes have been found after alprazolam administration (6,25,242), reflecting the inhibitory activity of alprazolam.”
BackgroundMataix-Cols, D., Alonso, P., Pifarré, J., Menchón, J. M., & Vallejo, J. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00024-0 · Cited by 116
“times (Allen et al., 1991), and impaired verbal”
Result
Metadata
- Authors
- Allen, D., Curran, H. V., & Lader, M.
- ORCID
- Curran, H. V.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1991-04
- Volume
- 40
- Issue
- 4
- Pages
- 355-362
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2073266088
- Cited by
- 51
- References
- 33
- Citations by year
- 2023: 2 · 2021: 3 · 2019: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2012: 2
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- clomipramine, alprazolam, repeated dosing, psychomotor performance, cognitive impairment, reaction time, word recall, forgetting, tolerance (pharmacology and immunology), somatic symptoms, benzodiazepines, tricyclic antidepressants, EEG, evoked potentials
- MeSH terms
- Adult, Affect, Alprazolam, Clomipramine, Cognition, Double-Blind Method, Electroencephalography, Evoked Potentials, Auditory, Female, Humans, Male, Memory, Middle Aged, Psychomotor Performance, Salivation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.